Restitution of defective glucose-stimulated insulin release of sulfonylurea type 1 receptor knockout mice by acetylcholine. 2004

Nicolai M Doliba, and Wei Qin, and Marko Z Vatamaniuk, and Changhong Li, and Dorothy Zelent, and Habiba Najafi, and Carol W Buettger, and Heather W Collins, and Richard D Carr, and Mark A Magnuson, and Franz M Matschinsky
Diabetes Research Center, Department of Biochemistry and Biophysics, Univ. of Pennsylvania, Philadelphia, PA 19104-6015, USA. nicolai@mail.med.upenn.edu

Inhibition of ATP-sensitive K+ (K(ATP)) channels by an increase in the ATP/ADP ratio and the resultant membrane depolarization are considered essential in the process leading to insulin release (IR) from pancreatic beta-cells stimulated by glucose. It is therefore surprising that mice lacking the sulfonylurea type 1 receptor (SUR1-/-) in beta-cells remain euglycemic even though the knockout is expected to cause hypoglycemia. To complicate matters, isolated islets of SUR1-/- mice secrete little insulin in response to high glucose, which extrapolates to hyperglycemia in the intact animal. It remains thus unexplained how euglycemia is maintained. In recognition of the essential role of neural and endocrine regulation of IR, we evaluated the effects of acetylcholine (ACh) and glucagon-like peptide-1 (GLP-1) on IR and free intracellular Ca2+ concentration ([Ca2+]i) of freshly isolated or cultured islets of SUR1-/- mice and B6D2F1 controls (SUR1+/+). IBMX, a phosphodiesterase inhibitor, was also used to explore cAMP-dependent signaling in IR. Most striking, and in contrast to controls, SUR1-/-) islets are hypersensitive to ACh and IBMX, as demonstrated by a marked increase of IR even in the absence of glucose. The hypersensitivity to ACh was reproduced in control islets by depolarization with the SUR1 inhibitor glyburide. Pretreatment of perifused SUR1-/- islets with ACh or IBMX restored glucose stimulation of IR, an effect expectedly insensitive to diazoxide. The calcium channel blocker verapamil reduced but did not abolish ACh-stimulated IR, supporting a role for intracellular Ca2+ stores in stimulus-secretion coupling. The effect of ACh on IR was greatly potentiated by GLP-1 (10 nM). ACh caused a dose-dependent increase in [Ca2+]i at 0.1-1 microM or biphasic changes (an initial sharp increase in [Ca2+]i followed by a sustained phase of low [Ca2+]i) at 1-100 microM. The latter effects were observed in substrate-free medium or in the presence of 16.7 mM glucose. We conclude that SUR1 deletion depolarizes the beta-cells and markedly elevates basal [Ca2+]i. Elevated [Ca2+]i in turn sensitizes the beta-cells to the secretory effects of ACh and IBMX. Priming by the combination of high [Ca2+]i, ACh, and GLP-1 restores the defective glucose responsiveness, precluding the development of diabetes but not effectively enough to cause hyperinsulinemic hypoglycemia.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007424 Intracellular Fluid The fluid inside CELLS. Fluid, Intracellular,Fluids, Intracellular,Intracellular Fluids
D007515 Islets of Langerhans Irregular microscopic structures consisting of cords of endocrine cells that are scattered throughout the PANCREAS among the exocrine acini. Each islet is surrounded by connective tissue fibers and penetrated by a network of capillaries. There are four major cell types. The most abundant beta cells (50-80%) secrete INSULIN. Alpha cells (5-20%) secrete GLUCAGON. PP cells (10-35%) secrete PANCREATIC POLYPEPTIDE. Delta cells (~5%) secrete SOMATOSTATIN. Islands of Langerhans,Islet Cells,Nesidioblasts,Pancreas, Endocrine,Pancreatic Islets,Cell, Islet,Cells, Islet,Endocrine Pancreas,Islet Cell,Islet, Pancreatic,Islets, Pancreatic,Langerhans Islands,Langerhans Islets,Nesidioblast,Pancreatic Islet
D008564 Membrane Potentials The voltage differences across a membrane. For cellular membranes they are computed by subtracting the voltage measured outside the membrane from the voltage measured inside the membrane. They result from differences of inside versus outside concentration of potassium, sodium, chloride, and other ions across cells' or ORGANELLES membranes. For excitable cells, the resting membrane potentials range between -30 and -100 millivolts. Physical, chemical, or electrical stimuli can make a membrane potential more negative (hyperpolarization), or less negative (depolarization). Resting Potentials,Transmembrane Potentials,Delta Psi,Resting Membrane Potential,Transmembrane Electrical Potential Difference,Transmembrane Potential Difference,Difference, Transmembrane Potential,Differences, Transmembrane Potential,Membrane Potential,Membrane Potential, Resting,Membrane Potentials, Resting,Potential Difference, Transmembrane,Potential Differences, Transmembrane,Potential, Membrane,Potential, Resting,Potential, Transmembrane,Potentials, Membrane,Potentials, Resting,Potentials, Transmembrane,Resting Membrane Potentials,Resting Potential,Transmembrane Potential,Transmembrane Potential Differences
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D010726 Phosphodiesterase Inhibitors Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. Phosphodiesterase Antagonists,Phosphodiesterase Inhibitor,Phosphoric Diester Hydrolase Inhibitors,Antiphosphodiesterases,Inhibitor, Phosphodiesterase
D011498 Protein Precursors Precursors, Protein
D011955 Receptors, Drug Proteins that bind specific drugs with high affinity and trigger intracellular changes influencing the behavior of cells. Drug receptors are generally thought to be receptors for some endogenous substance not otherwise specified. Drug Receptors,Drug Receptor,Receptor, Drug
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood

Related Publications

Nicolai M Doliba, and Wei Qin, and Marko Z Vatamaniuk, and Changhong Li, and Dorothy Zelent, and Habiba Najafi, and Carol W Buettger, and Heather W Collins, and Richard D Carr, and Mark A Magnuson, and Franz M Matschinsky
August 1995, Pancreas,
Nicolai M Doliba, and Wei Qin, and Marko Z Vatamaniuk, and Changhong Li, and Dorothy Zelent, and Habiba Najafi, and Carol W Buettger, and Heather W Collins, and Richard D Carr, and Mark A Magnuson, and Franz M Matschinsky
November 2005, Diabetes,
Nicolai M Doliba, and Wei Qin, and Marko Z Vatamaniuk, and Changhong Li, and Dorothy Zelent, and Habiba Najafi, and Carol W Buettger, and Heather W Collins, and Richard D Carr, and Mark A Magnuson, and Franz M Matschinsky
October 2002, The Journal of biological chemistry,
Nicolai M Doliba, and Wei Qin, and Marko Z Vatamaniuk, and Changhong Li, and Dorothy Zelent, and Habiba Najafi, and Carol W Buettger, and Heather W Collins, and Richard D Carr, and Mark A Magnuson, and Franz M Matschinsky
January 1991, Pharmacology,
Nicolai M Doliba, and Wei Qin, and Marko Z Vatamaniuk, and Changhong Li, and Dorothy Zelent, and Habiba Najafi, and Carol W Buettger, and Heather W Collins, and Richard D Carr, and Mark A Magnuson, and Franz M Matschinsky
July 2005, Brain research,
Nicolai M Doliba, and Wei Qin, and Marko Z Vatamaniuk, and Changhong Li, and Dorothy Zelent, and Habiba Najafi, and Carol W Buettger, and Heather W Collins, and Richard D Carr, and Mark A Magnuson, and Franz M Matschinsky
June 2002, Annals of surgery,
Nicolai M Doliba, and Wei Qin, and Marko Z Vatamaniuk, and Changhong Li, and Dorothy Zelent, and Habiba Najafi, and Carol W Buettger, and Heather W Collins, and Richard D Carr, and Mark A Magnuson, and Franz M Matschinsky
December 1999, Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology,
Nicolai M Doliba, and Wei Qin, and Marko Z Vatamaniuk, and Changhong Li, and Dorothy Zelent, and Habiba Najafi, and Carol W Buettger, and Heather W Collins, and Richard D Carr, and Mark A Magnuson, and Franz M Matschinsky
January 1997, Cell transplantation,
Nicolai M Doliba, and Wei Qin, and Marko Z Vatamaniuk, and Changhong Li, and Dorothy Zelent, and Habiba Najafi, and Carol W Buettger, and Heather W Collins, and Richard D Carr, and Mark A Magnuson, and Franz M Matschinsky
February 2011, Diabetes,
Nicolai M Doliba, and Wei Qin, and Marko Z Vatamaniuk, and Changhong Li, and Dorothy Zelent, and Habiba Najafi, and Carol W Buettger, and Heather W Collins, and Richard D Carr, and Mark A Magnuson, and Franz M Matschinsky
October 1999, Diabetes,
Copied contents to your clipboard!